SUBSCRIBE
SUBSCRIBE
News   Policy

Less Than Two Weeks Remain before Deadline in Class-Action Lawsuit Against Dendreon Corporation, Says Hagens Berman

September 22, 2011 | 
1 min read
SEATTLE--(BUSINESS WIRE)--Hagens Berman Sobol Shapiro LLP reminds investors that those who wish to serve as lead plaintiff in a class-action lawsuit against Dendreon (NASDAQ:DNDN) have less than two weeks from today to file their motion.
Legal
MORE ON THIS TOPIC
FDA
Unforced errors flummox HHS’ radical transparency bid—again
May 6, 2026
 · 
6 min read
 · 
Heather McKenzie
Recovering losses, effective economic measures to help alleviate inflation or economic crisis resulting in the collapse of the business economy or stock market, helping hands to catch gold coins rolling down a tilted cliff
Patents
Pfizer settles with generic drugmakers to protect blockbuster drug until 2031
April 29, 2026
 · 
2 min read
 · 
Nick Paul Taylor
man pulling each of the opposite ends of a rope in black and white, on a blue background with some blank space on top
Pancreatic cancer
Revolution levels legal threat on Erasca as pancreatic cancer rivalry heats up
April 28, 2026
 · 
3 min read
 · 
Tristan Manalac
Stack of coins balancing on seesaw over a bottle of pills.
Drug pricing
Regeneron finally joins Trump’s drug pricing push while notching landmark approval
April 24, 2026
 · 
2 min read
 · 
Tristan Manalac